Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-IL6 antibody (131-180 aa) (STJ96713) | Login | Anti-IL6 antibody (131-180 aa) (STJ96713) | ||||||||||||||||
|
||||||||||||||||||
Anti-KRT19 antibody (321-370 aa) (STJ96714) | Login | Anti-KRT19 antibody (321-370 aa) (STJ96714) | ||||||||||||||||
|
||||||||||||||||||
Anti-TFRC antibody (101-150 aa) (STJ96739) | Login | Anti-TFRC antibody (101-150 aa) (STJ96739) | ||||||||||||||||
|
||||||||||||||||||
Anti-JAG1 antibody (981-1030 aa) (STJ96766) | Login | Anti-JAG1 antibody (981-1030 aa) (STJ96766) | ||||||||||||||||
|
||||||||||||||||||
Anti-TNFSF11 antibody (268-317 aa) (STJ96769) | Login | Anti-TNFSF11 antibody (268-317 aa) (STJ96769) | ||||||||||||||||
|
||||||||||||||||||
Anti-TYMP antibody (11-60 aa) (STJ96779) | Login | Anti-TYMP antibody (11-60 aa) (STJ96779) | ||||||||||||||||
|
||||||||||||||||||
Anti-HSP70 antibody (STJ96789) | Login | Anti-HSP70 antibody (STJ96789) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGF8 antibody (141-190 aa) (STJ96802) | Login | Anti-FGF8 antibody (141-190 aa) (STJ96802) | ||||||||||||||||
|
||||||||||||||||||
Anti-APOA1 antibody (81-130 aa) (STJ96804) | Login | Anti-APOA1 antibody (81-130 aa) (STJ96804) | ||||||||||||||||
|
||||||||||||||||||
Anti-STX1A antibody (31-80 aa) (STJ96805) | Login | Anti-STX1A antibody (31-80 aa) (STJ96805) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGF16 antibody (141-190 aa) (STJ96806) | Login | Anti-FGF16 antibody (141-190 aa) (STJ96806) | ||||||||||||||||
|
||||||||||||||||||
Anti-IL12A antibody (31-80 aa) (STJ96807) | Login | Anti-IL12A antibody (31-80 aa) (STJ96807) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD3D antibody (41-90 aa) (STJ96823) | Login | Anti-CD3D antibody (41-90 aa) (STJ96823) | ||||||||||||||||
|
||||||||||||||||||
Anti-TNFRSF10C antibody (11-60 aa) (STJ96848) | Login | Anti-TNFRSF10C antibody (11-60 aa) (STJ96848) | ||||||||||||||||
|
||||||||||||||||||
Anti-HLA-DQB1/2 antibody (131-180 aa) (STJ96857) | Login | Anti-HLA-DQB1/2 antibody (131-180 aa) (STJ96857) | ||||||||||||||||
|
||||||||||||||||||
Anti-NCOA3 antibody (Internal) (STJ96872) | Login | Anti-NCOA3 antibody (Internal) (STJ96872) | ||||||||||||||||
|
||||||||||||||||||
Anti-FLT3LG antibody (171-220 aa) (STJ96881) | Login | Anti-FLT3LG antibody (171-220 aa) (STJ96881) | ||||||||||||||||
|
||||||||||||||||||
Anti-FAS antibody (51-100 aa) (STJ96891) | Login | Anti-FAS antibody (51-100 aa) (STJ96891) | ||||||||||||||||
|
||||||||||||||||||
Anti-CSF3R antibody (321-370 aa) (STJ96892) | Login | Anti-CSF3R antibody (321-370 aa) (STJ96892) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAP2K2 antibody [2C3] (STJ97518) | Login | Anti-MAP2K2 antibody [2C3] (STJ97518) | ||||||||||||||||
|
||||||||||||||||||
Anti-ERK1/2 antibody [6B1] (STJ97534) | Login | Anti-ERK1/2 antibody [6B1] (STJ97534) | ||||||||||||||||
|
||||||||||||||||||
Anti-P44/42 antibody [6C10] (STJ97536) | Login | Anti-P44/42 antibody [6C10] (STJ97536) | ||||||||||||||||
|
||||||||||||||||||
Anti-PRKAA1 antibody [5G11] (STJ97538) | Login | Anti-PRKAA1 antibody [5G11] (STJ97538) | ||||||||||||||||
|
||||||||||||||||||
Anti-LGALS3 antibody [8D7] (STJ97550) | Login | Anti-LGALS3 antibody [8D7] (STJ97550) | ||||||||||||||||
|
||||||||||||||||||
Anti-ARNT antibody [4C5] (STJ97602) | Login | Anti-ARNT antibody [4C5] (STJ97602) | ||||||||||||||||
|